214 related articles for article (PubMed ID: 34490997)
1. Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects.
Woo HY; Rhee H; Yoo JE; Kim SH; Choi GH; Kim DY; Woo HG; Lee HS; Park YN
Liver Int; 2022 Jan; 42(1):199-209. PubMed ID: 34490997
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypes and Tumor Immune Microenvironment in Hepatocellular Carcinoma With Macrotrabecular Massive and Vessels Encapsulating Tumor Clusters.
Akiba J; Nakayama M; Kondo R; Kusano H; Ogasawara S; Mihara Y; Tanigawa M; Tsutsui K; Yano Y; Miyazaki D; Tokisawa S; Mitsuhashi T; Nomura H; Sanada S; Sakai H; Hisaka T; Yano H
In Vivo; 2024; 38(2):640-646. PubMed ID: 38418151
[TBL] [Abstract][Full Text] [Related]
3. Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.
Kim YJ; Rhee H; Yoo JE; Alves VAF; Kim GJ; Kim HM; Herman P; Chagas A; Kim H; Park YN
Histopathology; 2017 Aug; 71(2):217-226. PubMed ID: 28326574
[TBL] [Abstract][Full Text] [Related]
4. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
[TBL] [Abstract][Full Text] [Related]
5. Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma.
Renne SL; Woo HY; Allegra S; Rudini N; Yano H; Donadon M; Viganò L; Akiba J; Lee HS; Rhee H; Park YN; Roncalli M; Di Tommaso L
Hepatology; 2020 Jan; 71(1):183-195. PubMed ID: 31206715
[TBL] [Abstract][Full Text] [Related]
6. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner.
Fang JH; Zhou HC; Zhang C; Shang LR; Zhang L; Xu J; Zheng L; Yuan Y; Guo RP; Jia WH; Yun JP; Chen MS; Zhang Y; Zhuang SM
Hepatology; 2015 Aug; 62(2):452-65. PubMed ID: 25711742
[TBL] [Abstract][Full Text] [Related]
7. Dual and opposing roles of the androgen receptor in VETC-dependent and invasion-dependent metastasis of hepatocellular carcinoma.
Zhou HC; Liu CX; Pan WD; Shang LR; Zheng JL; Huang BY; Chen JY; Zheng L; Fang JH; Zhuang SM
J Hepatol; 2021 Oct; 75(4):900-911. PubMed ID: 34004215
[TBL] [Abstract][Full Text] [Related]
8. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
[TBL] [Abstract][Full Text] [Related]
9. Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
Rhee H; Kim H; Park YN
Liver Cancer; 2020 Dec; 9(6):663-681. PubMed ID: 33442539
[TBL] [Abstract][Full Text] [Related]
10. Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.
Benzoubir N; Mussini C; Lejamtel C; Dos Santos A; Guillaume C; Desterke C; Samuel D; Bréchot C; Bourgeade MF; Guettier C
PLoS One; 2015; 10(6):e0130559. PubMed ID: 26110787
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-Mesenchymal Transition is Superior to Vessels-Encapsulate Tumor Cluster in Promoting Metastasis of Hepatocellular Carcinoma: a Morphological Evidence.
He C; Zhou Z; Jiang H; Yin Z; Meng S; Zhang J; Huang P; Xu K; Bian L; Xiao Z; Wang J
J Cancer; 2017; 8(1):39-47. PubMed ID: 28123596
[No Abstract] [Full Text] [Related]
12. Diagnostic and Prognostic Ability of Contrast-Enhanced Unltrasound and Biomarkers in Hepatocellular Carcinoma Subtypes.
Xu W; Huang B; Zhang R; Zhong X; Zhou W; Zhuang S; Xie X; Fang J; Xu M
Ultrasound Med Biol; 2024 Apr; 50(4):617-626. PubMed ID: 38281888
[TBL] [Abstract][Full Text] [Related]
13. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.
Govaere O; Komuta M; Berkers J; Spee B; Janssen C; de Luca F; Katoonizadeh A; Wouters J; van Kempen LC; Durnez A; Verslype C; De Kock J; Rogiers V; van Grunsven LA; Topal B; Pirenne J; Vankelecom H; Nevens F; van den Oord J; Pinzani M; Roskams T
Gut; 2014 Apr; 63(4):674-85. PubMed ID: 23958557
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior.
Kim GJ; Rhee H; Yoo JE; Ko JE; Lee JS; Kim H; Choi JS; Park YN
PLoS One; 2014; 9(8):e105094. PubMed ID: 25126747
[TBL] [Abstract][Full Text] [Related]
15. Can primary hepatocellular carcinoma histomorphology predict extrahepatic metastasis?
Kumar D; Hafez O; Jain D; Zhang X
Hum Pathol; 2021 Jul; 113():39-46. PubMed ID: 33905775
[TBL] [Abstract][Full Text] [Related]
16. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
[TBL] [Abstract][Full Text] [Related]
17. The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
Zhang P; Ono A; Fujii Y; Hayes CN; Tamura Y; Miura R; Shirane Y; Nakahara H; Yamauchi M; Uchikawa S; Uchida T; Teraoka Y; Fujino H; Nakahara T; Murakami E; Miki D; Kawaoka T; Okamoto W; Makokha GN; Imamura M; Arihiro K; Kobayashi T; Ohdan H; Fujita M; Nakagawa H; Chayama K; Aikata H
Int J Cancer; 2022 Dec; 151(12):2278-2290. PubMed ID: 36054900
[TBL] [Abstract][Full Text] [Related]
18. Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironments.
Kurebayashi Y; Matsuda K; Ueno A; Tsujikawa H; Yamazaki K; Masugi Y; Kwa WT; Effendi K; Hasegawa Y; Yagi H; Abe Y; Kitago M; Ojima H; Sakamoto M
Hepatology; 2022 May; 75(5):1139-1153. PubMed ID: 34657298
[TBL] [Abstract][Full Text] [Related]
19. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
[TBL] [Abstract][Full Text] [Related]
20. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
